CMS Releases Final Rule to Broaden Access to Health Data and Improve Prior Authorization
Key points: Prior authorization means that healthcare providers must get approval in advance from a health plan before providing a certain service (e.g., procedure or medication). The process can be...Read More
Highlights from PCF’s 30th Annual Scientific Retreat
PCF hosts an Annual Scientific Retreat to share the latest research findings, inspire collaboration, promote mentorship, and honor the newest awardees. Meeting sessions at the 30th Retreat addressed basic biology...Read More
Ken Garcia Shares His Journey Through Music: Join Us!
Ken Garcia is a person living with prostate cancer as well as a dentist and a musician. If you'll be in the greater San Diego area on February 25, you're...Read More
Patient Guide to Localized Prostate Cancer
If you have been diagnosed with prostate cancer and your doctor has told you that your cancer is early stage, still in the prostate, localized, curable with treatment, or low...Read More
Tomato-Pepper Rice
This simple, savory rice dish can be enjoyed as a side or as a main. Tomato and bell pepper add fiber and antioxidants; serve it with a simple green salad...Read More
Patient Guide to Recurrent and Metastatic Prostate Cancer
If you have been newly diagnosed with metastatic prostate cancer, you have many treatment options. If you have previously been treated for prostate cancer and your PSA is rising, or...Read More
Thank you for subscribing
Look for an email to confirm your subscription. Thank you for joining the Prostate Cancer Foundation community! As an email subscriber, you will hear from us periodically with the latest...Read More
The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Health Equity Research Challenge Awards
LOS ANGELES, Calif., November 30, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced three 2023 Bayer-PCF Health Equity Research Challenge Awards totaling $600,000. The awards will support...Read More
Breaking News: FDA Approves Enzalutamide as a Treatment Option for Patients with Recurrent Prostate Cancer at High Risk of Metastases
Patients who have been treated for localized prostate cancer and are now seeing their PSA rise rapidly are at high risk of metastasis and of death from prostate cancer. Now,...Read More
Staying Active, Staying Positive
Two and a half years ago, David Atkinson described his journey with advanced prostate cancer. A West Point graduate and Army veteran, he was treated by PCF-funded researcher and medical...Read More